… response to gefitinib with increasing age, especially in the first line treatment setting. … to be
increasing effect of gefitinib in non-small cell lung cancer patients. Further studies are needed …

… (3) Gefitinib and erlotinib are the first small molecule tyrosine … plus gefitinib in patients with
advanced non-small cell lung cancer … patients diagnosed with stage ⅢB/Ⅳ non-small cell lung …

… and Erlotinib for patients with advanced stage non-small-cell … with Erlotinib maintenance
therapy in patients with advanced … Gefitinib versus placebo as maintenance therapy in patients …

… ):Gefitinib及Erlotinib有大型臨床試驗(IPASS for Gefitinib; … to patients with advanced stage
non-small cell lung cancer (… Recent trials have shown a benefit of maintenance therapy after 4 to …

… free period after 1st line chemotherapy in advanced non-small cell lung cancer (NSCLC), most
of … EGFR-TKIs target therapy is a hot spot now. Gefitinib and erlotinib monotherapy have a …

… first-line treatment of advanced non-small cell lung cancer (NSCLC). … maintenance therapy
on overall survival in advanced … Erlotinib in previously treated non-small cell lung cancer[J]. N …

… therapy in patients with advanced non-small cell lung cancer (NSCLC). However, its effect in
the first-line treatment is … ）吉非替尼（gefitinib, Iressa）及厄洛替尼（erlotinib, Tarceva）的问世为…

… ):發生於5-20% 使用gefitinib 或 erlotinib 的病人,而佔了對第三代… Treatment paradigms for
advanced stage non-small cell lung … Erlotinib as maintenance treatment in advanced non-small-…

… Research progress of maintenance therapy in advanced non-small cell lung … of advanced
NSCLC maintenance therapy and discusses the clinical significance of maintenance therapy …

… , gefitinib and erlotinib, icotinib is similar to them in chemical structure, mechanism of activity
and therapeutic effects… in the treatment of the advanced non-small cell lung cancer (NSCLC) …